Hiroaki Yuasa

Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy Subjects

Hiroyuki Kusuhara, S Ito, Yoshito Kumagai et al. · Clinical Pharmacology & Therapeutics · 2011 · 215 citations

Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney

Sumito Ito, Hiroyuki Kusuhara, Miyu Yokochi et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 210 citations

PRIMe: A Web Site That Assembles Tools for Metabolomics and Transcriptomics

Kenji Akiyama, Eisuke Chikayama, Hiroaki Yuasa et al. · In Silico Biology · 2008 · 204 citations

Genetics, Metabolomic Profiling, Molecular Biology +19

Potent and Specific Inhibition of mMate1-Mediated Efflux of Type I Organic Cations in the Liver and Kidney by Pyrimethamine

Sumito Ito, Hiroyuki Kusuhara, Yushun Kuroiwa et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 152 citations

Identification and Functional Characterization of Rat Riboflavin Transporter 2

S. Yamamoto, Keiji Inoue, Kinya Ohta et al. · The Journal of Biochemistry · 2009 · 133 citations

Riboflavin Transport, Molecular Physiology, Biochemistry +12